Genes which positively correlated with ELF1 expression in prostate tumors were enriched for gene sets downregulated in prostate cancer, metastasis related pathways, and chemotherapy resistance; while genes that negatively correlated with ELF1 showed enrichment for gene sets upregulated in these same categories. This evidence concerns the gene ELF1 and prostate cancer.